AstraZeneca (AZN)

AstraZeneca Half-Year Profit Beat Eases Pipeline Worries: AZN Stock in Focus

AstraZeneca Stock: AZN Seeks EU Approval for Trixeo Aerosphere

EU Clears AstraZeneca's Etcamah Combination for First Line Breast Cancer

AstraZeneca Stock: Shares Slide After Rare Clinical Trial Failure

AstraZeneca Moves Closer to EU Approval of Trixeo Aerosphere for Asthma

AstraZeneca Stock: EU Approves New Breast Cancer Treatment

AstraZeneca Stock Slides After Clinical Trial Failure

AstraZeneca Wins EU Approval for Etcamah

Royalty pens $425M deal for slice of AstraZeneca ATTR drug sales

AstraZeneca Stock: New Deal Adds Lung Cancer Drug Worth Up to $1.5 Billion

AstraZeneca Stock in Focus After 1.5 Billion Dollar Dizal Lung Cancer Deal

AstraZeneca Stock in Focus After Azcuris Deal for Oral Asthma and Eczema Drug

AstraZeneca Stock Falls as HSBC Downgrades After Wainua Trial Miss

AstraZeneca Stock in Focus as Sino Biopharm Licensing Deal Adds to China Pipeline

AstraZeneca Trial Setback Puts Pipeline Premium Under Scrutiny

AstraZeneca Stock in Focus as ATTR-CM Trial Failure Aids Rival Pfizer

AstraZeneca Stock in Focus as Rival Padcev Keytruda Combo Wins Wider FDA Approval in Bladder Cancer

AstraZeneca Stock in Focus as Drug Trial Failure Wipes £20 Billion Off Value

AstraZeneca Wins US Appeals Court Ruling in Pfizer Cancer Drug Patent Fight

AstraZeneca and Ionis Heart Drug Wainua Falls Short in Trial

AstraZeneca Shares Slip After Ionis-Partnered Heart Trial Misses Goal

AstraZeneca Stock Slides on Ionis Trial Miss, but Setback May Be Overstated

AstraZeneca Wainua Trial Setback With Ionis Clouds Pipeline Growth

AstraZeneca Shares Fall After a Clinical Trial Setback

AstraZeneca Buys Ex-China Rights to Sino Biopharm COPD Drug for $2.1bn

AstraZeneca Signs Multi-Year Genomics Data Deal With Helix

AstraZeneca Nears NICE Pricing Deal for Enhertu Breast Cancer Drug

AstraZeneca Nears UK Price Deal With Daiichi For Cancer Drug Enhertu

AstraZeneca Pays $200m Upfront for Sino Biopharmaceutical COPD Drug

AstraZeneca and GSK Sign Separate Respiratory Licensing Deals With Sino Biopharm

AstraZeneca's Durvalumab Fails Lung Cancer Survival Trial

AstraZeneca Signs Up to 1.9 Billion Dollar Respiratory Deal With Sino Biopharma

AstraZeneca's Baxfendy Set for Blockbuster Sales After Hypertension Approval

AstraZeneca Signs Multi-Year Genomics Deal With Helix for Drug Discovery

Astrazeneca returns to tap China’s CSPC in $1.7B discovery deal

AstraZeneca Partners with Abbisko on Lung Cancer Drug Combination After China Trial Clearance

AstraZeneca's Enhertu Cancer Drug Gains Approval, Boosting Prospects

AstraZeneca Secures $1.7 Billion Kidney Drug Discovery Deal with Chinese Partner CSPC

AstraZeneca Collaborates on NSCLC Trial: Pipeline Expansion in Focus

AstraZeneca Secures Near $1.8 Billion Renal Disease Drug Deal with CSPC, Boosting Pipeline

AstraZeneca Secures Two EU Cancer Approvals, Advances Lung Cancer Trial

AstraZeneca Secures New $1.7 Billion Pact with CSPC: Pharmaceutical Stock in Focus

AstraZeneca Rallies on Oncology Approval and Pipeline Optimism

AstraZeneca Signs $1.77 Billion Drug Development Deal with China's CSPC

AstraZeneca taps China’s CSPC again, betting up to $1.77B to target kidney diseases

AstraZeneca Signs China Deal for Kidney Drugs: Pipeline Expansion in Focus

AstraZeneca Partners with CSPC for Renal Disease Drug in China, Boosting Pipeline

CSPC Pharmaceutical Enters Collaboration, Option & License Agreement With Astrazeneca For siRNA Drugs

AstraZeneca Begins Phase I/II Lung Cancer Drug Trial: Pipeline Boost for AZN

Abbisko, AstraZeneca Begin Phase I/II Trial of Lumipodlin With Osimertinib in EGFR-Mutant NSCLC

AstraZeneca Collaborates on Lung Cancer Drug Trial: AZN Shares in Focus

China's CSPC and AstraZeneca sign $1.77b drug development deal - China Daily

AstraZeneca Pays $34M to Settle Texas Kickback Lawsuit Over Free Nurses

AstraZeneca Secures EU Approval for Enhertu Cancer Treatment: Positive for Pharma Stock

AstraZeneca Unveils Strong Phase 3 Bone Disease Drug Data, Targeting $5 Billion Sales

AstraZeneca's Enhertu Wins EU Tumour-Agnostic Approval for HER2-Positive Cancers

AstraZeneca's Datroway Wins EU Regulator's Recommendation as First-Line Breast Cancer Treatment

AstraZeneca Faces German Drug Pricing Pressure, Lung Trial Results Awaited

AstraZeneca Daily Weight Loss Pill Shows Promising Trial Results

AstraZeneca Expands Obesity Drug Pipeline and Genetic Medicine Investment: Pharma Stock in Focus